(Q74545998)
Statements
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer (English)
C Aghajanian
D Fennelly
F Shapiro
R Waltzman
L Almadrones
C O'Flaherty
K O'Conner
E Venkatraman
R Barakat
J Curtin
C Brown
L Reich
D Wuest
L Norton
W Hoskins